Miller N E
Postgrad Med J. 1980 Aug;56(658):575-8. doi: 10.1136/pgmj.56.658.575.
There is now strong evidence that the risk of developing clinical coronary heart disease (CHD) in apparently healthy middle-aged men is inversely related to the plasma high density lipoprotein (HDL) cholesterol concentration. This reflects an underlying relationship between HDL cholesterol concentration and the severity of coronary atherosclerosis. This new information represents a significant development in atherosclerosis research. In the author's opinion, however, it is not yet justifiable, or indeed possible, to utilize this knowledge in CHD prevention programmes for 3 reasons. Firstly, there is still little prospective information on HDL and CHD in women, in younger subjects and in patients with existing clinical disease. Secondly, although there are at least 2 working hypotheses, a causal relationship between HDL metabolism and atherogenesis has not yet been established. Thirdly, there is still a relative paucity of information on the environmental determinants of HDL concentration and metabolism. Thus, premature attempts at intervention in an uncontrolled manner, and particularly the use of drugs for an HDL-raising effect, might only confuse the issue. While further research is being undertaken, attention should continue to be directed towards other reversible coronary risk factors (including hypercholesterolaemia, hypertension, and cigarette smoking) in CHD prevention programmes.
目前有强有力的证据表明,表面健康的中年男性患临床冠心病(CHD)的风险与血浆高密度脂蛋白(HDL)胆固醇浓度呈负相关。这反映了HDL胆固醇浓度与冠状动脉粥样硬化严重程度之间的潜在关系。这一新信息是动脉粥样硬化研究的一项重大进展。然而,在作者看来,基于以下三个原因,在冠心病预防计划中利用这一知识尚不具有合理性,甚至是不可能的。首先,关于女性、年轻受试者以及现有临床疾病患者中HDL与冠心病的前瞻性信息仍然很少。其次,尽管至少有两种可行的假设,但HDL代谢与动脉粥样硬化形成之间的因果关系尚未确立。第三,关于HDL浓度和代谢的环境决定因素的信息仍然相对匮乏。因此,过早地以不受控制的方式进行干预尝试,尤其是使用药物来提高HDL水平,可能只会使问题变得更加复杂。在进行进一步研究的同时,冠心病预防计划应继续关注其他可逆的冠心病风险因素(包括高胆固醇血症、高血压和吸烟)。